Sylentis ( Grupo PharmaMar ) ya Aparece como uno de los Posibles Actores en el Tratamiento del Dolor Ocular . Un Mercado al Alza en todo el Mundo .

New Report Examines the Growth of Ocular Pain Market Forecast to 2020

Press release from: Transparency Market Research

Ocular pain is also known as eye pain that occurs on the surface of the eye. Ocular pain is considered as a common medical condition that resolves on its own but, sometimes it creates emergency medical conditions. Possible causes for ocular pain includes corneal discomfort, pain in the sclera and discomfort in conjunctiva and pain in the iris.

Moreover, few other etiology of ocular pain includes pain in extracellular muscle of the eye, burning sensation in nerves present in the eye and paining sensation on the eyelids. Sinusitis, migraines, traumatic events and glaucoma are considered as few of medical conditions that can cause ocular pain. possible signs and symptoms of ocular pain includes pain in the eye, partial loss of vision, light sensitivity, double vision, halos vision, severe headache, irregularly shaped pupil, bulging eye and blood inside the front of eye. 

...

Some of the Major Players in the Ocular Pain Market are Sylentis S.A., Bayer AG, InSite Vision Incorporated, Reata Pharmaceuticals, Inc., Kala Pharmaceuticals, Inc., Bristol Meyer Squibb, Merck and Co. among others.

...